Novo Nordisk A/S - Depositary Receipt (Common Stock)
GB ˙ LSE ˙ US6701002056
43,26 USD ↓ -0,49 (-1,12%)
2026-06-05
PREZZO DELLE AZIONI
SecurityGB:0TDD / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionSolstein Capital, LLC
Latest Disclosed Ownership794 shares
Latest Disclosed Value $ 29,180
Solstein Capital, LLC ownership in 0TDD / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 14, 2026 - Solstein Capital, LLC filed a 13F-HR form disclosing ownership of 794 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (GB:0TDD) valued at $28,814 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 794 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $34,348 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 794 0 0.00 29 -27.50 0.0120
2026-02-13 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 794 0 0.00 40 -9.09 0.0162
2025-11-12 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 794 -14,483 -94.80 44 -95.83 0.0100
2025-08-01 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 15,277 0 0.00 1,054 -0.57 0.5412
2025-04-17 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 15,277 -5,560 -26.68 1,061 -40.85 0.6173
2025-02-13 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 20,837 -5,000 -19.35 1,792 -41.74 1.0017
2024-10-29 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 25,837 -5,000 -16.21 3,076 -30.11 1.6293
2024-07-26 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 30,837 0 0.00 4,402 11.16 2.8721
2024-04-24 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 30,837 -921 -2.90 3,959 20.52 2.7450
2024-01-23 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 31,758 28 0.09 3,285 13.86 2.4306
2023-10-25 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 31,730 15,865 100.00 2,886 12.39 2.4804
2023-07-27 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 15,865 190 1.21 2,567 2.93 2.1402
2023-04-19 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 15,675 -1,145 -6.81 2,495 9.58 2.1706
2023-02-02 2022-12-31 13F NOVO-NORDISK A S ADR 670100205 16,820 -1,764 -9.49 2,276 22.89 1.9045
2022-11-01 2022-09-30 13F NOVO-NORDISK A S ADR 670100205 18,584 144 0.78 1,852 -9.88 1.6316
2022-08-09 2022-06-30 13F NOVO-NORDISK A S ADR 670100205 18,440 193 1.06 2,055 1.43 1.5735
2022-05-05 2022-03-31 13F NOVO-NORDISK A S ADR 670100205 18,247 -544 -2.90 2,026 -3.75 1.3349
2022-01-27 2021-12-31 13F NOVO-NORDISK A S ADR 670100205 18,791 -391 -2.04 2,105 14.28 1.2688
2021-10-27 2021-09-30 13F NOVO-NORDISK A S ADR 670100205 19,182 12,760 198.69 1,842 242.38 1.0573
2021-08-12 2021-06-30 13F NOVO-NORDISK A S ADR ADR 670100205 6,422 -45 -0.70 538 23.39 0.6625
2021-05-13 2021-03-31 13F Novo Nordisk A ADR 670100205 6,467 1,380 27.13 436 22.47 0.5929
2021-02-11 2020-12-31 13F Novo Nordisk A Common 670100205 5,087 527 11.56 356 12.30 0.1467
2020-11-12 2020-09-30 13F Novo Nordisk A Common 670100205 4,560 -900 -16.48 317 -11.45 0.7101
2020-08-12 2020-06-30 13F Novo Nordisk A Common 670100205 5,460 5,460 358 0.8500
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.